Published in Eur J Hum Genet on June 01, 2013
Regulating biobanking with children's tissue: a legal analysis and the experts' view. Eur J Hum Genet (2015) 1.21
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet (2015) 1.21
Responsible implementation of expanded carrier screening. Eur J Hum Genet (2016) 0.92
Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology. Eur J Hum Genet (2013) 0.87
Expanded carrier screening panels-does bigger mean better? J Community Genet (2013) 0.83
Cost analysis of whole genome sequencing in German clinical practice. Eur J Health Econ (2016) 0.77
Virtual Pharmacist: A Platform for Pharmacogenomics. PLoS One (2015) 0.77
To disclose, or not to disclose? Context matters. Eur J Hum Genet (2014) 0.76
A Family-Centered Model for Sharing Genetic Risk. J Law Med Ethics (2015) 0.75
A map of human genome variation from population-scale sequencing. Nature (2010) 121.13
Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science (2009) 21.24
Genetic mapping in human disease. Science (2008) 15.12
A vision for the future of genomics research. Nature (2003) 14.06
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet (2010) 13.70
Clinical assessment incorporating a personal genome. Lancet (2010) 10.18
Letting the genome out of the bottle--will we get our wish? N Engl J Med (2008) 9.10
Copy-number variation and association studies of human disease. Nat Genet (2007) 8.50
Gene sequencing. The race for the $1000 genome. Science (2006) 6.76
Research ethics. Children and population biobanks. Science (2009) 3.95
Generic consent for genetic screening. N Engl J Med (1994) 3.91
Genome-based prediction of common diseases: advances and prospects. Hum Mol Genet (2008) 3.45
Genomic and personalized medicine: foundations and applications. Transl Res (2009) 3.24
Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 2.92
Next-generation sequencing: the race is on. Cell (2008) 2.86
ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol (2007) 2.69
Generations of sequencing technologies. Genomics (2008) 2.64
Newborn screening technology: proceed with caution. Pediatrics (2006) 2.54
Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol (2007) 2.40
Comparing whole genomes using DNA microarrays. Nat Rev Genet (2008) 2.27
[Rapid prenatal diagnosis of chromosomal abnormalities; limitations and possibilities]. Ned Tijdschr Geneeskd (2006) 2.06
The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update (2008) 2.04
A vision of the future of newborn screening. Pediatrics (2006) 2.04
Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing. J Med Genet (2009) 2.00
Ethical, legal, and practical concerns about recontacting patients to inform them of new information: the case in medical genetics. Am J Med Genet (2001) 1.91
Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet (2009) 1.91
Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics. Eur J Hum Genet (2009) 1.80
Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn (2009) 1.78
The moral obligation to create children with the best chance of the best life. Bioethics (2009) 1.68
Prenatal diagnosis of chromosomal abnormalities using array-based comparative genomic hybridization. Genet Med (2006) 1.63
Microarray genetic screening: a prenatal roadblock for life? Lancet (2007) 1.61
Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet (2009) 1.50
Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol (2002) 1.38
Newborn screening. Pathology (2008) 1.36
Successful pregnancies after application of array-comparative genomic hybridization in PGS-aneuploidy screening. Reprod Biomed Online (2008) 1.35
Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy. Am J Med Genet A (2006) 1.26
The $1000 genome: ethical and legal issues in whole genome sequencing of individuals. Am J Bioeth (2003) 1.20
The duty to recontact: attitudes of genetics service providers. Am J Hum Genet (1999) 1.19
A novel custom resequencing array for dilated cardiomyopathy. Genet Med (2010) 1.18
Genomic medicine: genetic variation and its impact on the future of health care. Philos Trans R Soc Lond B Biol Sci (2005) 1.16
Pre- and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives. Genet Med (2008) 1.16
Is there a case in favour of predictive genetic testing in young children? Bioethics (2001) 1.15
Ethical challenges in providing noninvasive prenatal diagnosis. Curr Opin Obstet Gynecol (2010) 1.15
Blurring lines. The research activities of direct-to-consumer genetic testing companies raise questions about consumers as research subjects. EMBO Rep (2010) 1.15
New challenges for informed consent through whole genome array testing. J Med Genet (2009) 1.10
What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee. Hum Reprod (2010) 1.10
Neonatal screening by DNA microarray: spots and chips. Nat Rev Genet (2005) 1.08
What next for preimplantation genetic screening? High mitotic chromosome instability rate provides the biological basis for the low success rate. Hum Reprod (2009) 1.08
Parents' interest in predictive genetic testing for their children when a disease has no treatment. Pediatrics (2009) 1.08
What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice? J Intern Med (2008) 1.07
Genetic research on stored tissue samples from minors: a systematic review of the ethical literature. Am J Med Genet A (2009) 1.07
The personal genome--the future of personalised medicine? Lancet (2010) 1.03
Increased nuchal translucency in euploid fetuses--what should we be telling the parents? Prenat Diagn (2010) 1.02
ESHRE Task Force on Ethics and Law 13: the welfare of the child in medically assisted reproduction. Hum Reprod (2007) 0.97
Comparison of multiplex ligation-dependent probe amplification and karyotyping in prenatal diagnosis. Obstet Gynecol (2010) 0.94
Predictive genetic testing for conditions that present in childhood. Kennedy Inst Ethics J (2002) 0.91
Current controversies in prenatal diagnosis 3: For prenatal diagnosis, should we offer less or more than metaphase karyotyping? Prenat Diagn (2009) 0.90
Chasing a disease to the vanishing point. Science (2010) 0.90
How attitudes research contributes to overoptimistic expectations of personal genome testing. Am J Bioeth (2009) 0.87
Comparative genomic hybridization and prenatal diagnosis. Curr Opin Obstet Gynecol (2006) 0.85
Evaluation of cystic fibrosis carrier screening programs according to genetic screening criteria. Genet Med (2002) 0.83
Genetic profiling of newborns: ethical and social issues. Nat Rev Genet (2006) 0.82
Public health genomics and genetic test evaluation: the challenge of conducting behavioural research on the utility of lifestyle-genetic tests. J Nutrigenet Nutrigenomics (2008) 0.80
[The scope of prenatal diagnostic testing for chromosomal aberrations: broad or narrow? Ethical considerations on the choice of tests]. Ned Tijdschr Geneeskd (2009) 0.80
Genomic medicine in prenatal diagnosis. Clin Obstet Gynecol (2008) 0.77
Why realistic test scenarios in translational genomics research remain hypothetical. Public Health Genomics (2009) 0.76
Heredity: science and society on the possibilities and limits of genetic testing and gene therapy. Report issued by a Committee of the Health Council of The Netherlands. Hum Gene Ther (1994) 0.76
Neonatal screening: old dogma or sound principle? Pediatrics (2007) 0.76
Let parents decide. Nature (2010) 0.76
[Neonatal screening: dynamics and ethics]. Ned Tijdschr Geneeskd (2005) 0.76
Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.93
Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet (2009) 1.50
Advances in prenatal screening: the ethical dimension. Nat Rev Genet (2011) 1.38
Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.31
Non-invasive prenatal diagnosis for aneuploidy: toward an integral ethical assessment. Hum Reprod (2011) 1.12
The new genetics and informed consent: differentiating choice to preserve autonomy. Bioethics (2013) 1.03
The scope of prenatal diagnosis for women at increased risk for aneuploidies: views and preferences of professionals and potential users. J Community Genet (2012) 0.89
Microarrays as a diagnostic tool in prenatal screening strategies: ethical reflection. Hum Genet (2014) 0.87
Rapid aneuploidy detection or karyotyping? Ethical reflection. Eur J Hum Genet (2011) 0.85
Prenatal screening: an ethical agenda for the near future. Bioethics (2015) 0.83
Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer (2013) 0.81
[The scope of prenatal diagnostic testing for chromosomal aberrations: broad or narrow? Ethical considerations on the choice of tests]. Ned Tijdschr Geneeskd (2009) 0.80
Advantages and Disadvantages of Different Implementation Strategies of Non-Invasive Prenatal Testing in Down Syndrome Screening Programmes. Public Health Genomics (2015) 0.77
Genomic sequencing in newborn screening programs. JAMA (2012) 0.75
Rapid aneuploidy screening. Hong Kong Med J (2011) 0.75